MonicaGrazziuttiMD
Infectious Disease • Little Rock, ARAssistant Professor, Internal Medicine, University of Arkansas COM
Dr. Grazziutti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
UAMS Medical Center
449 Jack Stephens Drive Winthrop P. Rockefeller Cancer Institute, Sixth Floor
Little Rock, AR 72205Phone+1 501-296-1200- Is this information wrong?
Education & Training
University of Texas Health Science Center at HoustonFellowship, Infectious Disease, 1994 - 1997
Universidad Nacional de Rosario Faculty of MedicineClass of 1982
Certifications & Licensure
AR State Medical License 2006 - 2025- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Therapeutic Research in Multiple Myeloma Start of enrollment: 2003 Aug 01
- UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma Start of enrollment: 2008 Jul 01
- Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy Start of enrollment: 2009 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 21 citationsThe prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtypeCarolina Schinke, Antje Hoering, Hongwei Wang, Victoria Carlton, Sharmilan Thanandrarajan, Shayu Deshpande, Purvi Patel, Gabor Molnar, Sandra Susanibar, Meera Mohan, P...> ;Haematologica. 2017 Aug 1
- 29 citationsClinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition diseaseMeera Mohan, Amy Buros, Pankaj Mathur, Neriman Gokden, Manisha Singh, Sandra Susanibar, Jorge Jo Kamimoto, Shadiqul Hoque, Muthukumar Radhakrishnan, Aasiya Matin, Cynt...> ;American Journal of Hematology. 2017 Aug 1
- 10 citationsAdverse metaphase cytogenetics can be overcome by adding bortezomib and thalidomide to fractionated melphalan transplantsYogesh Jethava, Alan Mitchell, Joshua Epstein, Maurizio Zangari, Shmuel Yaccoby, Erming Tian, Sarah Waheed, Rashid Z Khan, Xenofon Papanikolaou, Monica Grazziutti, Mic...> ;Clinical Cancer Research. 2017 Jun 1
- Join now to see all
Hospital Affiliations
UAMS Medical CenterLittle Rock, Arkansas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
